Dr Awa Aidara-Kane holds a PhD in Microbiology from University of Technology of Compiegne, France. She has been associate Professor of Bacteriology and Virology in Senegal and Head of the Laboratory of Research in Bacteriology and Food Hygiene and Environment at Pasteur Institute in Senegal.
Dr Awa Aidara-Kane joined WHO in 2002 and is Coordinator of Foodborne and Zoonotic Diseases Unit, in the Department of Food Safety and Zoonoses at the World Health Organization in Geneva, Switzerland.. She is leading WHO activities on integrated surveillance of foodborne diseases and containment of Antimicrobial Resistance (AMR) at the human-animal interface. She has established and is coordinating the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) . Awa Aidara-Kane is WHO focal point for FAO/OIE/WHO Tripartite collaboration on Antimicrobial Resistance and is leading WHO “One Health” work stream for the implementation of the Global Action Plan on Antimicrobial Resistance.
She has successfully coordinated many WHO guidance documents, guidelines , expert meetings and technical workshops in the area of foodborne diseases surveillance and antimicrobial resistance.
1. South African Society of Clinical Microbiologists –Past Chairperson
2. Federation of South African Society of Pathologists – Past President
3. South African Antibiotic Stewardship Working Group
4. Ministerial advisory board on antimicrobial resistance
5. Colleges of Medicine South Africa (CMSA)
6. Federation of Infectious Diseases South Africa (FIDDSA)
7. Registered with Health Professions Council of South Africa (HPCSA)
Laxminarayan is founder and director of the Center for Disease Dynamics, Economics & Policy (CDDEP) in Washington, D.C., and a senior research scholar and lecturer at the Princeton Environmental Institute at Princeton University. He is an affiliate professor at the University of Washington and a visiting professor at the University of Strathclyde in Scotland and at the University of Kwazulu Natal in South Africa. Laxminarayan is founder of HealthCube, which works to improve access to healthcare and diagnostics worldwide.
Since 1995, Laxminarayan has worked to improve the understanding of antibiotic resistance as a problem of managing a shared global resource. His work encompasses extensive peer-reviewed research, public outreach, and direct engagement in eleven countries in Asia and Africa through the Global Antibiotic Resistance Partnership. Through his prolific research, active public outreach (including a widely viewed TED talk) and sustained policy engagement, he has played a central role in bringing the issue of drug resistance to the attention of leaders and policymakers worldwide and to the United Nations General Assembly in September 2016. Laxminarayan has served on the U.S. President’s Council of Advisors on Science and Technology’s antimicrobial resistance working group and is currently a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance. He is a series editor of the Disease Control Priorities for Developing Countries, 3rd edition.
In 2003-04, he served on the National Academy of Science/Institute of Medicine Committee on the Economics of Antimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. In 2012, Laxminarayan created the Immunization Technical Support Unit that supports the immunization program of the Ministry of Health and Family Welfare of the Government of India and which is credited with helping rapidly improve vaccination coverage and introduction of four new vaccines. As Vice President, Research and Policy at the Public Health Foundation of India between 2011 and 2015, he led the growth of a research division to over 700 technical and research staff. Laxminarayan’s work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC, NPR, Reuters, Science, Wall Street Journal, and National Journal.
Dr Krishnee Moodley (MBChB, FCPath (Micro), MMed (Micro)) is a medical microbiologist since 2008, currently at Lancet Laboratories since 2012. She has worked in both public and private sector microbiology laboratories. Her interests include diagnostic testing for antimicrobial resistance, as well as bacterial infections in children. She has published on various aspects of antimicrobial resistance and resistance testing.
She is a member of the following professional bodies:
- Federation of Infectious Diseases South Africa (FIDDSA)
- South African Society of Clinical Microbiologists (SASCM) – member of editorial committee
- National Antibiotic committee (NAC)
- South African Medical Association (SAMA)
- Kwa-Zulu Natal Specialists Network (KZNSN)
- Pneumococcal disease in children
- Antimicrobial resistance
Gunnar Skov Simonsen MD, PhD (born 1965) is Professor and Director at the Department of Microbiology and Infection Control at the University Hospital of North Norway in Tromsø, Norway. He is in charge of NORM – The Norwegian Organization for Surveillance of Antimicrobial Resistance. He has co-authored more than 80 papers in international peer-reviewed journals. Simonsen has previously served as Medical Officer at WHO HQ in Geneva (2002 – 2003). Simonsen is the Norwegian National Focal Point for AMR at the European Center for Disease Prevention and Control (ECDC) as well as member of the Coordination Group for the European Antimicrobial Resistance Surveillance Network (EARS-Net). He worked 2012-2013 at the WHO Collaborating Center for Surveillance of Antimicrobial Resistance at Brigham and Women´s Hospital / Harvard Medical School in Boston (USA). Since 2015 he has served as member of the Scientific Advisory Board of the EU Joint Programming Initiative for Antimicrobial Resistance (JPI-AMR).
Lars Småbrekke (born 1959), Cand.Pharm, MPH & PhD, is associate professor and head of the IPSUM research group at Department of Pharmacy at UiT – The Arctic University of Norway. Småbrekke has previously served as a hospital pharmacist at the University hospital of North Norway, and co-authored several issues of the regional antibiotic treatment guidelines while holding this position. He established and headed the Regional Drug Information Centre for North Norway before taking a position at UiT – The Arctic University of Norway. Småbrekke has served several periods as a member of the National Board of Pharmacovigilance and the National Board of Reimbursement. He is currently a member of the Regional Health Authority.
Dr. John Stelling is Co-Director of the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance based at the Brigham and Women’s Hospital in Boston. He received his undergraduate degree from Johns Hopkins University and Master’s in Public Health from the Johns Hopkins School of Hygiene and Public Health. In 1991, Dr. Stelling graduated from Harvard Medical School and the Massachusetts Institute of Technology Division of Health Sciences and Technology and in 1995 completed an internship in family practice at San Francisco General Hospital.
The focus of his work has been to support public health infrastructure for laboratory services, including three years as a Medical Officer with the World Health Organization Antimicrobial Resistance Monitoring Unit, and advancing data management tools for laboratory-based surveillance of infectious diseases and antimicrobial resistance. Since 1989, He has developed, disseminated and supported the free WHONET software, currently used to support surveillance activities in over 120 countries in over 2,300 hospital, public health, food, and veterinary laboratories.
Dr Khine Swe Swe/Han has completed her MB, BS at the age of 25 years from Myanmar Medical University and was working continuously as clinical doctor for 14 years (1985-1998) before qualified as a pathologist. She arrived in South Africa in 1999 and she was appointed as a senior lecturer (part time), Medical Microbiology Department at MEDUNSA (University of Limpopo). In 2001, National Health Laboratory Service (NHLS) appointed her as a registrar. She obtained the postgraduate degrees such as; FC Path, MMed (Medical Microbiology), DTMH; PDIC from South Africa University School of Medicine. She has awarded PhD in 2017 (Thesis titles: A novel standardized approach to the treatment and management of significant Acinetobacter species infection in KwaZulu-Natal).
In 2005- 2006; she worked as a Clinical Pathologist, Consultant/ In- charge, NHLS, Kalafong hospital, Northern branch, Pretoria Academic complex. She was a Laboratory in-charge for Microbiology, Virology, Haematology and Chemical pathology services and provided the service for Outreach program: 10 laboratories under Rekopane (e.g. Jubilee). She analyzed the Multidrug resistant organisms (MDROs) surveillance and highly involved in hospital infection control team and outbreak investigation (example; Schistosomiasis outbreak community public health). She taught the in-service training, medical microbiology lecture to the 6th year MBChB students, internal medicine registrars, intern doctors and community doctors at Kalafong academic hospital.
In 2006 October, she moved to the Stanger Hospital as a Clinical Pathologist, HOD (laboratory, Pathology of Infectious diseases and communicable diseases Department), Stanger Hospital, KZN, and Department of Health. She was a chair for Infection prevention control and Antibiotic policy committee. She taught medical microbiology to the different level of health care workers (medical doctors, community and intern doctors, nurses, CSSD, Physiotherapist and occupational health safety department). After 6 months in Stanger hospital, she was promoted as a senior specialist.
Currently (2007-present) she is a principal specialist/Senior Consultant/Lecturer of NHLS, University of KwaZulu Natal, IALCH academic complex Hospital. She is a chairperson of Infection control committee for 10 years. She led the FIFA 2010 outbreak investigation, relevant training workshops in KZN in 2010. Currently she participates as a major role for Antibiotics stewardship program (ASWP) and chairperson of ASWP. She served the hospital service, Laboratory management including national coverage, in-service training, She is a Senior Consultant/Pathologist (D4 level –Deputy HOD) of NHLS, and joint post of lecturer at University of KwaZulu- Natal, IALCH academic Hospital.
She deeply involves in academic teaching undergraduate (MBChB year 2, 3, 4 & 6; BMEDSC year 3), postgraduate program (MMed & ID registrars), internal and external examiners, CMSA exam coordinator and invited as an observer. She has published 19 papers, 38 oral/ poster presentations and a reviewer. She supervises the postgraduate students (MMed): Honours students and contributor/co-author of PhD student’s research. Her interesting areas/professional fields are antimicrobial resistance multidrug resistant organisms (MDROs), surveillance of MDROs, their relevant controls and antibiotics stewardship program. She started to find out the Glycopeptide intermediate resistant Staphylococcus aureus (GISA/ hGISA) at local hospital (IALCH) and the carbapenem resistant Enterobacteraecae (CRE) also during analyzed the surveillance data. She participates as an editorial board member of SASCM; FIDSSA, National antimicrobial committee (NAC), Working group committee of C.Diff; Honourable Editorial Board member, CMSA, IPCAN, EC Pharmacology and Toxicology and Senate UKZN Member. She also appointed as Honorary Research of Fellow in the school of Health Science, University of KwaZulu Natal, Westville Campus. She has agreed to involve as a Collaborator / supervisor for The “One Health” Approach to Containing Antibiotic Resistance Research Project.
Professor Neil Woodford is Head of the Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit at Public Health England. His Unit, based at Colindale, north London, is a WHO Collaborating Centre. Neil is an Honorary Professor at the University of KwaZulu-Natal and at University College London, and is a Visiting Professor at Imperial College London where he also did his doctoral studies on resistance in Neisseria gonorrhoeae. Neil has worked on antimicrobial resistance for over three decades and has co-authored over 400 publications on diverse aspects of this subject.
Neil sits on many national and international committees relating to antimicrobial resistance, and served as the Scientific Advisor to Lord Jim O’Neill’s Review on Antimicrobial Resistance (2014-16).